Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Revvity, Inc. (NYSE:RVTY - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 145,980 shares of the company's stock, valued at approximately $16,293,000. Universal Beteiligungs und Servicegesellschaft mbH owned 0.12% of Revvity at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. Assetmark Inc. increased its stake in Revvity by 3,700.0% in the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock worth $30,000 after buying an additional 259 shares during the period. Optiver Holding B.V. bought a new position in Revvity during the 4th quarter worth about $33,000. Quarry LP grew its holdings in Revvity by 45.7% during the 4th quarter. Quarry LP now owns 303 shares of the company's stock worth $34,000 after acquiring an additional 95 shares in the last quarter. Millstone Evans Group LLC bought a new position in Revvity during the 4th quarter worth about $38,000. Finally, Vermillion Wealth Management Inc. bought a new position in Revvity during the 4th quarter worth about $41,000. Hedge funds and other institutional investors own 86.65% of the company's stock.
Analysts Set New Price Targets
Several research analysts have issued reports on RVTY shares. Robert W. Baird dropped their target price on shares of Revvity from $127.00 to $125.00 and set an "outperform" rating on the stock in a report on Tuesday, April 29th. Wall Street Zen cut shares of Revvity from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. UBS Group upgraded shares of Revvity from a "neutral" rating to a "buy" rating and dropped their target price for the stock from $145.00 to $115.00 in a report on Thursday, May 1st. Wells Fargo & Company dropped their target price on shares of Revvity from $130.00 to $102.00 and set an "equal weight" rating on the stock in a report on Thursday, April 17th. Finally, KeyCorp increased their target price on shares of Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Five equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $125.64.
Read Our Latest Stock Report on RVTY
Revvity Stock Up 1.6%
Shares of NYSE:RVTY traded up $1.44 during trading on Tuesday, reaching $90.76. The stock had a trading volume of 168,807 shares, compared to its average volume of 949,309. Revvity, Inc. has a one year low of $87.92 and a one year high of $129.50. The company has a market capitalization of $10.70 billion, a P/E ratio of 41.07, a PEG ratio of 3.82 and a beta of 1.02. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. The firm's 50-day simple moving average is $94.66 and its 200 day simple moving average is $107.96.
Revvity (NYSE:RVTY - Get Free Report) last released its earnings results on Monday, April 28th. The company reported $1.01 EPS for the quarter, topping analysts' consensus estimates of $0.96 by $0.05. The company had revenue of $664.76 million during the quarter, compared to analysts' expectations of $662.30 million. Revvity had a net margin of 9.81% and a return on equity of 7.68%. Revvity's revenue for the quarter was up 2.3% on a year-over-year basis. During the same period last year, the business earned $0.98 EPS. As a group, research analysts expect that Revvity, Inc. will post 4.94 EPS for the current fiscal year.
Revvity Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.31%. The ex-dividend date is Friday, July 18th. Revvity's dividend payout ratio (DPR) is 11.91%.
About Revvity
(
Free Report)
Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Recommended Stories

Before you consider Revvity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.
While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.